In vivo molecular imaging
- 1 January 2002
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 87 (S39) , 231-238
- https://doi.org/10.1002/jcb.10450
Abstract
The relatively young field of molecular imaging is focused on the visualization of molecular phenotypes in whole organisms. This is achieved using imaging systems based on radionuclides, nuclear magnetic resonance, ultrasound, or the visible‐IR region of the optical spectrum. Molecularly defined contrast in these modalities is generated by exogenous probes of the endogenous proteome, or through transgenes. Examples of exogenous probes include those that are transported and trapped (glucose, nucleoside analogs), those directed against extracellular receptors (somatostatin, opioid, melanotropin), and those activated by extracellular proteases. Transgenes that have been used in molecular imaging include the above receptors, non‐mammalian enzymes that trap pro‐drugs (HSV‐tk, yeast CD), and optical reporter proteins (luciferase, fluorescent proteins). Cutting edge technologies in this field include in vivo assays for protein‐protein interactions, and in vivo assays for mRNA expression patterns. The number of degrees of freedom in designing new agents is daunting, and advancements in this field will require a significant participation from molecular and cellular biochemists. J. Cell. Biochem. Suppl. 39: 231–238, 2002.Keywords
This publication has 35 references indexed in Scilit:
- Advances in In Vivo Bioluminescence Imaging of Gene ExpressionAnnual Review of Biomedical Engineering, 2002
- ?-melanocyte-stimulating hormone peptide analogs labeled with technetium-99m and indium-111 for malignant melanoma targetingCancer, 2002
- Scaling down imaging: molecular mapping of cancer in miceNature Reviews Cancer, 2002
- A Noninvasive Reporter System to Image Adenoviral-Mediated Gene Transfer to Ovarian Cancer XenograftsGynecologic Oncology, 2001
- Targeted ultrasonic contrast agents for molecular imaging and therapyProgress in Cardiovascular Diseases, 2001
- What does positron emission tomography offer oncology?European Journal Of Cancer, 2000
- Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticlesMagnetic Resonance in Medicine, 2000
- Primary structure of the Aequorea victoria green-fluorescent proteinGene, 1992
- Nuclear Magnetic Resonance Technology for Medical StudiesScience, 1984
- Medical imaging by NMRThe British Journal of Radiology, 1977